Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 305

1.

Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six-month results of a prospective randomized clinical trial.

Pielen A, Mirshahi A, Feltgen N, Lorenz K, Korb C, Junker B, Schaefer C, Zwiener I, Hattenbach LO; RABAMES Study Group.

Acta Ophthalmol. 2015 Feb;93(1):e29-37. doi: 10.1111/aos.12488. Epub 2014 Jul 8.

2.

Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion.

Tan MH, McAllister IL, Gillies ME, Verma N, Banerjee G, Smithies LA, Wong WL, Wong TY.

Am J Ophthalmol. 2014 Jan;157(1):237-247.e1. doi: 10.1016/j.ajo.2013.08.013. Epub 2013 Oct 7.

PMID:
24112635
3.

Scatter Photocoagulation Does Not Reduce Macular Edema or Treatment Burden in Patients with Retinal Vein Occlusion: The RELATE Trial.

Campochiaro PA, Hafiz G, Mir TA, Scott AW, Solomon S, Zimmer-Galler I, Sodhi A, Duh E, Ying H, Wenick A, Shah SM, Do DV, Nguyen QD, Kherani S, Sophie R.

Ophthalmology. 2015 Jul;122(7):1426-37. doi: 10.1016/j.ophtha.2015.04.006. Epub 2015 May 9.

PMID:
25972260
4.

Combined intravitreal bevacizumab and grid laser photocoagulation for macular edema secondary to branch retinal vein occlusion.

Donati S, Barosi P, Bianchi M, Al Oum M, Azzolini C.

Eur J Ophthalmol. 2012 Jul-Aug;22(4):607-14. doi: 10.5301/ejo.5000085.

PMID:
22101497
5.

Comparative evaluation between ranibizumab combined with laser and bevacizumab combined with laser versus laser alone for macular oedema secondary to branch retinal vein occlusion.

Azad SV, Salman A, Mahajan D, Sain S, Azad R.

Middle East Afr J Ophthalmol. 2014 Oct-Dec;21(4):296-301. doi: 10.4103/0974-9233.142264.

6.

Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.

Mitry D, Bunce C, Charteris D.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD009510. doi: 10.1002/14651858.CD009510.pub2. Review.

PMID:
23440840
7.

Subthreshold grid laser versus intravitreal bevacizumab as second-line therapy for macular edema in branch retinal vein occlusion recurring after conventional grid laser treatment.

Parodi MB, Iacono P, Bandello F.

Graefes Arch Clin Exp Ophthalmol. 2015 Oct;253(10):1647-51. doi: 10.1007/s00417-014-2845-6. Epub 2014 Nov 11.

PMID:
25382074
8.

Combination therapy with dexamethasone intravitreal implant and macular grid laser in patients with branch retinal vein occlusion.

Pichi F, Specchia C, Vitale L, Lembo A, Morara M, Veronese C, Ciardella AP, Nucci P.

Am J Ophthalmol. 2014 Mar;157(3):607-15.e1. doi: 10.1016/j.ajo.2013.11.016. Epub 2013 Nov 27.

PMID:
24528934
9.

Comparison of clinical efficacy of intravitreal ranibizumab with and without triamcinolone acetonide in macular edema secondary to central retinal vein occlusion.

Fan C, Wang Y, Ji Q, Zhao B, Xie J.

Curr Eye Res. 2014 Sep;39(9):938-43. doi: 10.3109/02713683.2014.885533. Epub 2014 Mar 17.

PMID:
24635755
10.

Intravitreal injection of bevacizumab combined with macular grid laser photocoagulation for macular edema in branch retinal vein occlusion.

Hayashi A, Yunoki T, Miyakoshi A, Mitarai K, Fujino T, Yanagisawa S.

Jpn J Ophthalmol. 2011 Nov;55(6):625-31. doi: 10.1007/s10384-011-0087-2. Epub 2011 Sep 9.

PMID:
21909658
11.

Early peripheral laser photocoagulation of nonperfused retina improves vision in patients with central retinal vein occlusion (Results of a proof of concept study).

Rehak M, Tilgner E, Franke A, Rauscher FG, Brosteanu O, Wiedemann P.

Graefes Arch Clin Exp Ophthalmol. 2014 May;252(5):745-52. doi: 10.1007/s00417-013-2528-8. Epub 2013 Dec 18.

PMID:
24346235
12.

A randomised, double-masked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal vein occlusion: MARVEL Report No. 1.

Narayanan R, Panchal B, Das T, Chhablani J, Jalali S, Ali MH; MARVEL study group.

Br J Ophthalmol. 2015 Jul;99(7):954-9. doi: 10.1136/bjophthalmol-2014-306543. Epub 2015 Jan 28.

PMID:
25631483
13.

Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.

Puche N, Glacet A, Mimoun G, Zourdani A, Coscas G, Soubrane G.

Acta Ophthalmol. 2012 Jun;90(4):357-61. doi: 10.1111/j.1755-3768.2010.01913.x. Epub 2010 Jun 29.

14.

Intravitreal bevacizumab combined with grid photocoagulation in recurrent macular edema secondary to retinal vein occlusion.

Farese E, Cennamo G, Velotti N, Traversi C, Rinaldi M, De Crecchio G.

Eur J Ophthalmol. 2014 Sep-Oct;24(5):761-70. doi: 10.5301/ejo.5000448. Epub 2014 Feb 26.

PMID:
24585424
15.

The REVEAL Study: Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Asian Patients with Diabetic Macular Edema.

Ishibashi T, Li X, Koh A, Lai TY, Lee FL, Lee WK, Ma Z, Ohji M, Tan N, Cha SB, Shamsazar J, Yau CL; REVEAL Study Group.

Ophthalmology. 2015 Jul;122(7):1402-15. doi: 10.1016/j.ophtha.2015.02.006. Epub 2015 May 14.

PMID:
25983216
16.

Effect of leaking perifoveal microaneurysms on resolution of diabetic macular edema treated by combination therapy using anti-vascular endothelial growth factor and short pulse focal/grid laser photocoagulation.

Hirano T, Toriyama Y, Iesato Y, Imai A, Hirabayashi K, Nagaoka T, Takamura Y, Sugimoto M, Murata T.

Jpn J Ophthalmol. 2017 Jan;61(1):51-60. doi: 10.1007/s10384-016-0483-8. Epub 2016 Oct 11.

PMID:
27730425
17.

Reading speed improvements in retinal vein occlusion after ranibizumab treatment.

Suñer IJ, Bressler NM, Varma R, Lee P, Dolan CM, Ward J, Colman S, Rubio RG.

JAMA Ophthalmol. 2013 Jul;131(7):851-6. doi: 10.1001/jamaophthalmol.2013.114.

PMID:
23699977
18.

Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study.

Campochiaro PA, Sophie R, Pearlman J, Brown DM, Boyer DS, Heier JS, Marcus DM, Feiner L, Patel A; RETAIN Study Group.

Ophthalmology. 2014 Jan;121(1):209-19. doi: 10.1016/j.ophtha.2013.08.038. Epub 2013 Oct 7.

PMID:
24112944
19.

Effect of leaking capillaries and microaneurysms in the perifoveal capillary network on resolution of macular edema by anti-vascular endothelial growth factor treatment.

Iesato Y, Imai A, Hirano T, Toriyama Y, Murata T.

Jpn J Ophthalmol. 2016 Mar;60(2):86-94. doi: 10.1007/s10384-016-0425-5. Epub 2016 Jan 22.

PMID:
26801502
20.

Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.

Solaiman KA, Diab MM, Abo-Elenin M.

Retina. 2010 Nov-Dec;30(10):1638-45. doi: 10.1097/IAE.0b013e3181e1ed07.

PMID:
20838357

Supplemental Content

Support Center